Purchases and Sales Made in Q3 2024 in Vaneck ETF Tr Biotech ETF (BBH)
This table provides information about the institutional ownership of Vaneck ETF Tr Biotech ETF (BBH) during Q3 2024. The information is specifically focused on institutions that hold shares of VANECK ETF TR BIOTECH ETF.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Boston Research & Management Inc
Manchester, MA |
SELL
|
- |
-670- 5.42% |
$112K - $122K
|
11.7K
$1.92M
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.77K- 18.68% |
$463K - $507K
|
12.1K
$1.98M
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-3.22K- 6.49% |
$538K - $589K
|
46.5K
$7.62M
|
|
|
Nov 14, 2024
Q3 2024
|
Miller Investment Management, LP
West Conshohocken, PA |
SELL
|
- |
-4.2K- 4.04% |
$701K - $767K
|
99.8K
$16.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-8.05K- 26.35% |
$1.34M - $1.47M
|
22.5K
$3.69M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-8.74K- 82.36% |
$1.46M - $1.6M
|
1.87K
$307K
|